Cargando…

Current progress in perioperative chemotherapy for biliary tract cancer

Biliary tract cancer (BTCs) is a heterogeneous malignancy divided into cholangiocarcinoma, gallbladder cancer, and ampullary cancer. Due to little or no symptoms, most patients with BTCs are diagnosed with unresectable or metastatic disease. Only 20%–30% of all BTCs are suitable for potentially rese...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ioka, Tatsuya, Shindo, Yoshitaro, Ueno, Makoto, Nagano, Hiroaki
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10319609/ https://www.ncbi.nlm.nih.gov/pubmed/37416744 http://dx.doi.org/10.1002/ags3.12691

Ejemplares similares

Essential updates to the surgical treatment of biliary tract cancer
por: Matsukuma, Satoshi, et al.
Publicado: (2019)

Clinical outcomes of second‑line chemotherapy after gemcitabine and cisplatin plus S‑1 treatment for patients with advanced biliary tract cancer in the KHBO1401‑3A study
por: Shindo, Yoshitaro, et al.
Publicado: (2023)

Impact of conversion surgery after chemotherapy in patients with initially unresectable and recurrent biliary tract cancer
por: Nakamura, Ikuo, et al.
Publicado: (2023)

Randomized phase III study of gemcitabine, cisplatin plus S‐1 versus gemcitabine, cisplatin for advanced biliary tract cancer (KHBO1401‐ MITSUBA)
por: Ioka, Tatsuya, et al.
Publicado: (2022)

Current status of chemotherapy for the treatment of advanced biliary tract cancer
por: Sasaki, Takashi, et al.
Publicado: (2013)

Pharmacokinetic Study of Adjuvant Gemcitabine Therapy for Biliary Tract Cancer following Major Hepatectomy (KHBO1101)
por: Fujiwara, Yutaka, et al.
Publicado: (2015)

Chemotherapy for Biliary Tract Cancer in 2021
por: Sasaki, Takashi, et al.
Publicado: (2021)

Novel Biomarkers for Personalized Cancer Immunotherapy
por: Shindo, Yoshitaro, et al.
Publicado: (2019)

The impact of peritoneal lavage cytology in biliary tract cancer (KHBO1701): Kansai Hepato‐Biliary Oncology Group
por: Matsukuma, Satoshi, et al.
Publicado: (2020)

Phase I study of adjuvant chemotherapy with gemcitabine plus cisplatin in patients with biliary tract cancer undergoing curative resection without major hepatectomy (KHBO1004)
por: Toyoda, Masanori, et al.
Publicado: (2014)

Current Status and Future Perspectives of Perioperative Therapy for Resectable Biliary Tract Cancer: A Multidisciplinary Review
por: Yoo, Changhoon, et al.
Publicado: (2021)

Tolerability and efficacy of durvalumab, either as monotherapy or in combination with tremelimumab, in patients from Asia with advanced biliary tract, esophageal, or head‐and‐neck cancer
por: Doki, Yuichiro, et al.
Publicado: (2022)

Current Progress and Future Perspectives of Immune Checkpoint Inhibitors in Biliary Tract Cancer
por: Seesaha, Poshita-Kumari, et al.
Publicado: (2021)

A prospective multicenter phase II study of FOLFIRINOX as a first-line treatment for patients with advanced and recurrent biliary tract cancer
por: Takahara, Naminatsu, et al.
Publicado: (2022)

Histological complete response in a patient with advanced biliary tract cancer treated by gemcitabine/cisplatin/S-1 combination chemotherapy: A case report
por: Matsubara, Tokuhiro, et al.
Publicado: (2016)

Biliary tract cancer: current challenges and future prospects
por: Ghidini, Michele, et al.
Publicado: (2018)

Biliary Tract Cancer: Current Medical Treatment Strategies
por: Oneda, Ester, et al.
Publicado: (2020)

Association between a single nucleotide polymorphism in the R3HCC1 gene and irinotecan toxicity
por: Kanesada, Kou, et al.
Publicado: (2022)

Research Progress of Biliary Tract Cancers
por: Fonkoua, Lionel Aurelien A. Kankeu, et al.
Publicado: (2021)

Adjuvant Radio-chemotherapy for extrahepatic biliary tract cancers
por: Bonet Beltrán, Marta, et al.
Publicado: (2011)

Efficacy and safety of trametinib in Japanese patients with advanced biliary tract cancers refractory to gemcitabine
por: Ikeda, Masafumi, et al.
Publicado: (2017)

Immunotherapy in Biliary Tract Cancers: Current Standard-of-Care and Emerging Strategies
por: Lo, Justin H., et al.
Publicado: (2023)

Biliary tract cancers: current knowledge, clinical candidates and future challenges
por: Tariq, Noor-ul-Ain, et al.
Publicado: (2019)

Pancreatic Cancer Stem-Like Cells With High Calreticulin Expression Associated With Immune Surveillance
por: Fujiwara, Yasuhiro, et al.
Publicado: (2021)

Application and utility of surgical techniques for cystic plate isolation in liver surgery
por: Tokumitsu, Yukio, et al.
Publicado: (2022)

A novel prediction model of pancreatic fistula after pancreaticoduodenectomy using only preoperative markers
por: Matsui, Hiroto, et al.
Publicado: (2023)

Guidelines for chemotherapy of biliary tract and ampullary carcinomas
por: Furuse, Junji, et al.
Publicado: (2008)

Safety and Effectiveness of Chemotherapy in Elderly Biliary Tract Cancer Patients
por: Okamoto, Takeshi, et al.
Publicado: (2023)

The clinical outcomes of combination chemotherapy in elderly patients with advanced biliary tract cancer: an exploratory analysis of JCOG1113
por: Yamada, Ikuhiro, et al.
Publicado: (2022)

An Assessment of Combination of the Camrelizumab With Chemotherapy in Metastatic Biliary Tract Cancers
por: Yu, Yi, et al.
Publicado: (2021)

Current options and future directions of systemic therapy for advanced biliary tract cancer
por: Prete, Maria Giuseppina, et al.
Publicado: (2021)

Biliary tract large cell neuroendocrine carcinoma: current evidence
por: Raiker, Riva, et al.
Publicado: (2019)

Paradigm shift of chemotherapy and systemic treatment for biliary tract cancer
por: Leowattana, Wattana, et al.
Publicado: (2023)

Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer
por: Harder, J, et al.
Publicado: (2006)

Perioperative chemotherapy in the management of high risk upper tract urothelial cancers
por: Kaag, Matthew G.
Publicado: (2020)

CD4 and FOXP3 as predictive markers for the recurrence of T3/T4a stage II colorectal cancer: applying a novel discrete Bayes decision rule
por: Nakagami, Yuki, et al.
Publicado: (2022)

Comparison of gemcitabine-based chemotherapies for advanced biliary tract cancers by renal function: an exploratory analysis of JCOG1113
por: Ueno, Makoto, et al.
Publicado: (2021)

Determining the protective characteristics and risk factors for the development of anastomotic leakage after low anterior resection for rectal cancer
por: Suzuki, Nobuaki, et al.
Publicado: (2020)

Adjuvant therapy of biliary tract cancers
por: Kefas, Joanna, et al.
Publicado: (2023)

Targeted Therapy for Biliary Tract Cancer
por: Furuse, Junji, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_e3bb1hjdb8mgd8sqsc16pbgqtg